The marijuana industry cynically hid pro-pot amendments in the must-pass annual National Defense Authorization Act (NDAA) – but yesterday the House Rules Committee rejected them all. “We are encouraged they looked at the law, medical science and data,” SAM president Kevin Sabet commented.


